Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
93pct
196d open
vs 5,674 other S bills in the 119th — cohort avg 32d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (11)
Placed on Senate Legislative Calendar under General Orders. Calendar No. 164.
Committee on Homeland Security and Governmental Affairs. Reported by Senator Paul without amendment. Without written report.
Committee on Homeland Security and Governmental Affairs. Ordered to be reported without amendment favorably.
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2026 · third_quarter · Science/Technology
(H.R.8845/S.TBD) - FY2027 Commerce, Justice, Science, and Related Agencies Appropriations Act, Title I and Title III, all provisions related to research and education in NASA, NSF, NIST, and NOAA. (H.R.9022/S.TBD) - FY2027 Appropriations for Energy and Water Development, Title III - all provisions related to science and research, including nuclear physics research facilities. Full funding for the CHIPS and Science Act of 2022 (P.L. 117-167) - which re-authorized and re-designated the research missions of the National Science Foundation (NSF); spur domestic innovation of advanced technologies through basic and applied research; authorized new R&D programs across federal research agencies; and for other purposes. Proposals to protect university IP, including under potential Bayh-Dole "march in" rights, and mitigate nefarious influence from hostile foreign actors. S.854/H.R.1864 - Risky Research Review Act - whole bill, potential impact on bio-medical research, regulatory burden, and efforts to increase oversight and accountability. Proposed regulatory changes to Facilities and Administration (F&A) cost agreements/negotiated indirect cost reimbursements for federally sponsored research, including the proposed FAIR Model for indirect cost reimbursements. Language in the CR(P.L 119-103) temporarily blocking implementation of proposed the OMB Uniform Guidance Proposed Rule EOs, grant rescissions/cancellations, regulatory changes, and policy shifts that affect faculty, researchers, students, programs, and core research and education missions.
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Science/Technology
Proposed cap of 15% on F&A expenditures (NIH, NSF, DoD, DOE) and the FAIR Model as the proposed alternative developed by a group of Subject Matter Experts as well as higher education and research advocacy associations Updates on impacts of Executive Orders and agency directives on U-M operations and funded research projects CREATE AI Act of 2025 (H.R. 2385) Deterrent Act (H.R. 1048) Risky Research Review Act (S. 854/H.R. 1864) Investing in National Next-Generation Opportunities for Venture Acceleration and Technological Excellence (INNOVATE) Act (S. 853) SBIR/STTR reauthorization - potential provisions related to undue foreign influence Policy related to AI research and funding, including the Department of Energy Genesis Mission, and Department of Energy and National Nuclear Security Administration computational research Issues pertaining to science and security, including research security engagements with the Department of Defense/Department of War H.R. 3838/S. 2296 - 2026 National Defense Authorization Act (P.L. 119-60) H.R. 8800/S. 4784 - National Defense Authorization Act for FY27 (NDAA) H.R. 881 - DHS Restrictions on Confucius Institutes and Chinese Entities of Concern Act H.R. 1082 - Cell and Tissue Product Safety Securing American Funding and Expertise from Adversarial Research Exploitation Act of 2025 BIOSECURE Act SAFE Research Act Discussion of proposals that would impact the Bayh-Dole Act, including related impact on university technology transfer programs, and university licensing revenue Proposed revisions to 2 CFR Part 200 (Uniform Guidance) H.R. 10574 - American Leadership in Fusion Act Future of Ultra-Intense Laser Science Research and User Facilities
Client expense: $150,000 · Firm income: Not reported
2026 · third_quarter · Science/Technology
Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235); Cloud Labs to Advance Biotechnology Act of 2025 (S. 2676); Homestake AI Act of 2026 (S. 4991).
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Science/Technology
Artificial Intelligence; Research security; S.854/H.R. 1864 - Risky Research Review Act; H.R. 1048/S.1296 - the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act; H.R. 9102, the Biotech Investment National Security Act of 2026
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Medical/Disease Research/Clinical Labs
Issue: Educate Congress and the administration about the impact of regulatory burden on medical research. Issue: Oppose inappropriate use of march-in authority. Issue: Educate Congress and the administration about opportunities to strengthen medical research supported by National Institutes of Health (NIH). H.R.1864/S.854 - Risky Research Review Act Issue: Support prevention of unintended consequences from new restrictions on life sciences research. H.R.1863/S.855 - Royalty Transparency Act Issue: Support efforts to ensure the National Institutes of Health (NIH) peer review system is not hampered. Issue: Avoid unnecessary restrictions on types of research including human embryonic stem cell, fetal tissue, gain of function, and animal research. H.Res.708 - Recognizing the contributions of medical research and observing "Medical Research Week" from September 15 through September 19, 2025. Issue: Educate Congress about the importance of National Institutes of Health (NIH)-supported medical research. P.L.119-60 - National Defense Authorization Act for Fiscal Year 2026 H.R.3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 S.1071 - National Defense Authorization Act for Fiscal Year 2026 Issue: Provide comments on provisions to strengthen research, including rejecting inclusion of subtitle D, SAFE Research Act. S.5295 - NIH Mentorship Modernization Act Issue: Provide feedback on National Institutes of Health (NIH) research training and mentors. Issue: Suggest opportunities to strengthen support for clinical trials. Issue: Educate Congress and the administration on challenges associated with slow pace of National Institutes of Health (NIH) obligations.
Government targets: Defense, Dept of (DOD), Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), SENATE
Client expense: $431,446 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
2026 · third_quarter · Science/Technology
Artificial Intelligence; Research security; S.854/H.R. 1864 - Risky Research Review Act; H.R. 1048/S.1296 - the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act; H.R. 9102, the Biotech Investment National Security Act of 2026
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Government Issues
Lobbied in support of H.R. 2550 / S. 2837, the Protect Americas Workforce Act to restore collective bargaining rights at several federal agencies, including several DHS agencies, including USCIS. Lobbied in support of Discharge Petition 6 that would make in order H.R. 2550 / S. 2837, the Protect American Workers Act to restore collective bargaining rights at several federal agencies. Lobbied against the nomination of Paul Ingrassia to head the Office of Special Counsel. Lobbied against the nomination Charles Arrington to serve on the Federal Labor Relations Authority. Lobbied against S. 854, Risky Research Review Act Lobbied in support of S. 572, Shadow Wolves Improvement Act Lobbied in opposition to H.R. 1210, the Protecting Taxpayers Wallet Act Lobbied in opposition to H.R. 2249, the Preserving Presidential Management Authority Act Lobbied in opposition to H.R. 2174, the Paycheck Protection Act Lobbied against the confirmation of Scott Kupur to be the director of the Office of Management and Budget Lobbied against the confirmation of Eric M. Ueland to be Deputy Director for Management, Office of Management and Budget Lobbied in support of H.R. 493 and S. 126 the Federal Adjustment of Income Rates Act Lobbied in support of the "DC Admissions Act," H.R. 51 and S. 51 to make the D.C. a state. Lobbied in support of passage of S. 1077 to prevent massive budget cuts to D.C. budget Lobbied in support of H.R. 491, the "Equal COLA Act" for Federal Employee Retirement System beneficiaries' cost-of-living adjustment to be the same as Civil Service Retirement System benefits rather than arbitrarily cut by one full percentage point. Lobbied in support of H.R. 1835 the Model Employee Reinstatement for Ill-advised Termination (MERIT) Act to reinstate federal employees who were unjustly fired by Donald Trump and Elon Musks DOGE initiative that targeted federal workers. In addition to rehiring these workers, the MERIT Act gives them the back pay they deserve. Lobbied in support of H.R. 492 and S. 134, the Saving the Civil Service Act to prevent the politicization of the non-partisan civil service by limiting the conversion of federal jobs from the competitive service to the excepted service without congressional approval. Lobbied in support of H.R. 759 the Federal Firefighter's Families First Act to include mandatory overtime hours worked into the calculation of retirement benefits Lobbied in support of H.R. 1637 and S. 914 the Protect Veterans Jobs Act to reinstate veterans who were fired from their jobs a during the Trump Administration and DOGE purge of federal employees. Lobbied in support of H.R. 1989 the Protect Our Probationary Employees Act to ensure that if terminated probationary employees are reinstated, they will not need to restart their probationary period for the same job they previously held and can continue to do the important work of the American people. Lobbied in support of H.R. 2470 the COST of Relocations Act to require a cost-benefit analysis to be submitted to Congress to ensure that any attempt to move federal agencies is appropriately analyzed to guarantee it is in the best interest of the taxpayer and the agencys mission. Lobbied the House and Senate on H.R. 1 reconciliation opposing cuts to FERS and FEHB and changes to Title 5 workplace rules to pay for the bills tax cuts. Lobbied the House and Senate on H.R. 4, the Rescissions Act of 2025, to oppose rescissions to the U.S. Agency for International Development (USAID), the U.S. Department of State and the Corporation for Public Broadcasting. Lobbied House and Senate appropriators about FY26 appropriations. Lobbied the House and Senate on FY 2026 reconciliation opposing cuts to FERS and FEHB to pay for 2017 tax cuts. Lobbied against passage of H.R. 473, the "SHOW UP Act" and its provisions that would abrogate collective bargaining agreements. Lobbied against cutting services at federal agencies, pay and benefits of federal employees, Social Security and Medicare as a precondition of raising the debt ceiling. Lobbied in support of amendments to the House and Senate budget resolutions to restore collective bargaining rights. Lobbied on behalf of Social Security workforce on agency funding, the collective bargaining agreement, telework, and recruitment and retention benefits. Lobbied in support of H.R. 2086 and S. 997 the "Rights for the TSA Workforce Act to provide full title 5 collective bargaining rights for transportation security officers.
Client expense: $410,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2026 · first_quarter · Government Issues
Lobbied in support of H.R. 2550 / S. 2837, the Protect Americas Workforce Act to restore collective bargaining rights at several federal agencies, including several DHS agencies, including USCIS. Lobbied in support of Discharge Petition 6 that would make in order H.R. 2550 / S. 2837, the Protect American Workers Act to restore collective bargaining rights at several federal agencies. Lobbied against the nomination of Paul Ingrassia to head the Office of Special Counsel. Lobbied against the nomination Charles Arrington to serve on the Federal Labor Relations Authority. Lobbied against S. 854, Risky Research Review Act Lobbied in support of S. 572, Shadow Wolves Improvement Act Lobbied in opposition to H.R. 1210, the Protecting Taxpayers Wallet Act Lobbied in opposition to H.R. 2249, the Preserving Presidential Management Authority Act Lobbied in opposition to H.R. 2174, the Paycheck Protection Act Lobbied against the confirmation of Scott Kupur to be the director of the Office of Management and Budget Lobbied against the confirmation of Eric M. Ueland to be Deputy Director for Management, Office of Management and Budget Lobbied in support of H.R. 493 and S. 126 the Federal Adjustment of Income Rates Act Lobbied in support of the "DC Admissions Act," H.R. 51 and S. 51 to make the D.C. a state. Lobbied in support of passage of S. 1077 to prevent massive budget cuts to D.C. budget Lobbied in support of H.R. 491, the "Equal COLA Act" for Federal Employee Retirement System beneficiaries' cost-of-living adjustment to be the same as Civil Service Retirement System benefits rather than arbitrarily cut by one full percentage point. Lobbied in support of H.R. 1835 the Model Employee Reinstatement for Ill-advised Termination (MERIT) Act to reinstate federal employees who were unjustly fired by Donald Trump and Elon Musks DOGE initiative that targeted federal workers. In addition to rehiring these workers, the MERIT Act gives them the back pay they deserve. Lobbied in support of H.R. 492 and S. 134, the Saving the Civil Service Act to prevent the politicization of the non-partisan civil service by limiting the conversion of federal jobs from the competitive service to the excepted service without congressional approval. Lobbied in support of H.R. 759 the Federal Firefighter's Families First Act to include mandatory overtime hours worked into the calculation of retirement benefits Lobbied in support of H.R. 1637 and S. 914 the Protect Veterans Jobs Act to reinstate veterans who were fired from their jobs a during the Trump Administration and DOGE purge of federal employees. Lobbied in support of H.R. 1989 the Protect Our Probationary Employees Act to ensure that if terminated probationary employees are reinstated, they will not need to restart their probationary period for the same job they previously held and can continue to do the important work of the American people. Lobbied in support of H.R. 2470 the COST of Relocations Act to require a cost-benefit analysis to be submitted to Congress to ensure that any attempt to move federal agencies is appropriately analyzed to guarantee it is in the best interest of the taxpayer and the agencys mission. Lobbied the House and Senate on H.R. 1 reconciliation opposing cuts to FERS and FEHB and changes to Title 5 workplace rules to pay for the bills tax cuts. Lobbied the House and Senate on H.R. 4, the Rescissions Act of 2025, to oppose rescissions to the U.S. Agency for International Development (USAID), the U.S. Department of State and the Corporation for Public Broadcasting. Lobbied House and Senate appropriators about FY26 appropriations. Lobbied the House and Senate on FY 2026 reconciliation opposing cuts to FERS and FEHB to pay for 2017 tax cuts. Lobbied against passage of H.R. 473, the "SHOW UP Act" and its provisions that would abrogate collective bargaining agreements. Lobbied against cutting services at federal agencies, pay and benefits of federal employees, Social Security and Medicare as a precondition of raising the debt ceiling. Lobbied in support of amendments to the House and Senate budget resolutions to restore collective bargaining rights. Lobbied on behalf of Social Security workforce on agency funding, the collective bargaining agreement, telework, and recruitment and retention benefits. Lobbied in support of H.R. 2086 and S. 997 the "Rights for the TSA Workforce Act to provide full title 5 collective bargaining rights for transportation security officers.
Client expense: $410,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2026 · second_quarter · Government Issues
Lobbied in support of H.R. 2550 / S. 2837, the Protect Americas Workforce Act to restore collective bargaining rights at several federal agencies, including several DHS agencies, including USCIS. Lobbied in support of Discharge Petition 6 that would make in order H.R. 2550 / S. 2837, the Protect American Workers Act to restore collective bargaining rights at several federal agencies. Lobbied against the nomination of Paul Ingrassia to head the Office of Special Counsel. Lobbied against the nomination Charles Arrington to serve on the Federal Labor Relations Authority. Lobbied against S. 854, Risky Research Review Act Lobbied in support of S. 572, Shadow Wolves Improvement Act Lobbied in opposition to H.R. 1210, the Protecting Taxpayers Wallet Act Lobbied in opposition to H.R. 2249, the Preserving Presidential Management Authority Act Lobbied in opposition to H.R. 2174, the Paycheck Protection Act Lobbied against the confirmation of Scott Kupur to be the director of the Office of Management and Budget Lobbied against the confirmation of Eric M. Ueland to be Deputy Director for Management, Office of Management and Budget Lobbied in support of H.R. 493 and S. 126 the Federal Adjustment of Income Rates Act Lobbied in support of the "DC Admissions Act," H.R. 51 and S. 51 to make the D.C. a state. Lobbied in support of passage of S. 1077 to prevent massive budget cuts to D.C. budget Lobbied in support of H.R. 491, the "Equal COLA Act" for Federal Employee Retirement System beneficiaries' cost-of-living adjustment to be the same as Civil Service Retirement System benefits rather than arbitrarily cut by one full percentage point. Lobbied in support of H.R. 1835 the Model Employee Reinstatement for Ill-advised Termination (MERIT) Act to reinstate federal employees who were unjustly fired by Donald Trump and Elon Musks DOGE initiative that targeted federal workers. In addition to rehiring these workers, the MERIT Act gives them the back pay they deserve. Lobbied in support of H.R. 492 and S. 134, the Saving the Civil Service Act to prevent the politicization of the non-partisan civil service by limiting the conversion of federal jobs from the competitive service to the excepted service without congressional approval. Lobbied in support of H.R. 759 the Federal Firefighter's Families First Act to include mandatory overtime hours worked into the calculation of retirement benefits Lobbied in support of H.R. 1637 and S. 914 the Protect Veterans Jobs Act to reinstate veterans who were fired from their jobs a during the Trump Administration and DOGE purge of federal employees. Lobbied in support of H.R. 1989 the Protect Our Probationary Employees Act to ensure that if terminated probationary employees are reinstated, they will not need to restart their probationary period for the same job they previously held and can continue to do the important work of the American people. Lobbied in support of H.R. 2470 the COST of Relocations Act to require a cost-benefit analysis to be submitted to Congress to ensure that any attempt to move federal agencies is appropriately analyzed to guarantee it is in the best interest of the taxpayer and the agencys mission. Lobbied the House and Senate on H.R. 1 reconciliation opposing cuts to FERS and FEHB and changes to Title 5 workplace rules to pay for the bills tax cuts. Lobbied the House and Senate on H.R. 4, the Rescissions Act of 2025, to oppose rescissions to the U.S. Agency for International Development (USAID), the U.S. Department of State and the Corporation for Public Broadcasting. Lobbied House and Senate appropriators about FY26 appropriations. Lobbied the House and Senate on FY 2026 reconciliation opposing cuts to FERS and FEHB to pay for 2017 tax cuts. Lobbied against passage of H.R. 473, the "SHOW UP Act" and its provisions that would abrogate collective bargaining agreements. Lobbied against cutting services at federal agencies, pay and benefits of federal employees, Social Security and Medicare as a precondition of raising the debt ceiling. Lobbied in support of amendments to the House and Senate budget resolutions to restore collective bargaining rights. Lobbied on behalf of Social Security workforce on agency funding, the collective bargaining agreement, telework, and recruitment and retention benefits. Lobbied in support of H.R. 2086 and S. 997 the "Rights for the TSA Workforce Act to provide full title 5 collective bargaining rights for transportation security officers.
Client expense: $410,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2026 · second_quarter · Government Issues
Lobbied in support of H.R. 2550 / S. 2837, the Protect Americas Workforce Act to restore collective bargaining rights at several federal agencies, including several DHS agencies, including USCIS. Lobbied in support of Discharge Petition 6 that would make in order H.R. 2550 / S. 2837, the Protect American Workers Act to restore collective bargaining rights at several federal agencies. Lobbied against the nomination of Paul Ingrassia to head the Office of Special Counsel. Lobbied against the nomination Charles Arrington to serve on the Federal Labor Relations Authority. Lobbied against S. 854, Risky Research Review Act Lobbied in support of S. 572, Shadow Wolves Improvement Act Lobbied in opposition to H.R. 1210, the Protecting Taxpayers Wallet Act Lobbied in opposition to H.R. 2249, the Preserving Presidential Management Authority Act Lobbied in opposition to H.R. 2174, the Paycheck Protection Act Lobbied against the confirmation of Scott Kupur to be the director of the Office of Management and Budget Lobbied against the confirmation of Eric M. Ueland to be Deputy Director for Management, Office of Management and Budget Lobbied in support of H.R. 493 and S. 126 the Federal Adjustment of Income Rates Act Lobbied in support of the "DC Admissions Act," H.R. 51 and S. 51 to make the D.C. a state. Lobbied in support of passage of S. 1077 to prevent massive budget cuts to D.C. budget Lobbied in support of H.R. 491, the "Equal COLA Act" for Federal Employee Retirement System beneficiaries' cost-of-living adjustment to be the same as Civil Service Retirement System benefits rather than arbitrarily cut by one full percentage point. Lobbied in support of H.R. 1835 the Model Employee Reinstatement for Ill-advised Termination (MERIT) Act to reinstate federal employees who were unjustly fired by Donald Trump and Elon Musks DOGE initiative that targeted federal workers. In addition to rehiring these workers, the MERIT Act gives them the back pay they deserve. Lobbied in support of H.R. 492 and S. 134, the Saving the Civil Service Act to prevent the politicization of the non-partisan civil service by limiting the conversion of federal jobs from the competitive service to the excepted service without congressional approval. Lobbied in support of H.R. 759 the Federal Firefighter's Families First Act to include mandatory overtime hours worked into the calculation of retirement benefits Lobbied in support of H.R. 1637 and S. 914 the Protect Veterans Jobs Act to reinstate veterans who were fired from their jobs a during the Trump Administration and DOGE purge of federal employees. Lobbied in support of H.R. 1989 the Protect Our Probationary Employees Act to ensure that if terminated probationary employees are reinstated, they will not need to restart their probationary period for the same job they previously held and can continue to do the important work of the American people. Lobbied in support of H.R. 2470 the COST of Relocations Act to require a cost-benefit analysis to be submitted to Congress to ensure that any attempt to move federal agencies is appropriately analyzed to guarantee it is in the best interest of the taxpayer and the agencys mission. Lobbied the House and Senate on H.R. 1 reconciliation opposing cuts to FERS and FEHB and changes to Title 5 workplace rules to pay for the bills tax cuts. Lobbied the House and Senate on H.R. 4, the Rescissions Act of 2025, to oppose rescissions to the U.S. Agency for International Development (USAID), the U.S. Department of State and the Corporation for Public Broadcasting. Lobbied House and Senate appropriators about FY26 appropriations. Lobbied the House and Senate on FY 2026 reconciliation opposing cuts to FERS and FEHB to pay for 2017 tax cuts. Lobbied against passage of H.R. 473, the "SHOW UP Act" and its provisions that would abrogate collective bargaining agreements. Lobbied against cutting services at federal agencies, pay and benefits of federal employees, Social Security and Medicare as a precondition of raising the debt ceiling. Lobbied in support of amendments to the House and Senate budget resolutions to restore collective bargaining rights. Lobbied on behalf of Social Security workforce on agency funding, the collective bargaining agreement, telework, and recruitment and retention benefits. Lobbied in support of H.R. 2086 and S. 997 the "Rights for the TSA Workforce Act to provide full title 5 collective bargaining rights for transportation security officers.
Client expense: $410,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2026 · first_quarter · Government Issues
Lobbied in support of H.R. 2550 / S. 2837, the Protect Americas Workforce Act to restore collective bargaining rights at several federal agencies, including several DHS agencies, including USCIS. Lobbied in support of Discharge Petition 6 that would make in order H.R. 2550 / S. 2837, the Protect American Workers Act to restore collective bargaining rights at several federal agencies. Lobbied against the nomination of Paul Ingrassia to head the Office of Special Counsel. Lobbied against the nomination Charles Arrington to serve on the Federal Labor Relations Authority. Lobbied against S. 854, Risky Research Review Act Lobbied in support of S. 572, Shadow Wolves Improvement Act Lobbied in opposition to H.R. 1210, the Protecting Taxpayers Wallet Act Lobbied in opposition to H.R. 2249, the Preserving Presidential Management Authority Act Lobbied in opposition to H.R. 2174, the Paycheck Protection Act Lobbied against the confirmation of Scott Kupur to be the director of the Office of Management and Budget Lobbied against the confirmation of Eric M. Ueland to be Deputy Director for Management, Office of Management and Budget Lobbied in support of H.R. 493 and S. 126 the Federal Adjustment of Income Rates Act Lobbied in support of the "DC Admissions Act," H.R. 51 and S. 51 to make the D.C. a state. Lobbied in support of passage of S. 1077 to prevent massive budget cuts to D.C. budget Lobbied in support of H.R. 491, the "Equal COLA Act" for Federal Employee Retirement System beneficiaries' cost-of-living adjustment to be the same as Civil Service Retirement System benefits rather than arbitrarily cut by one full percentage point. Lobbied in support of H.R. 1835 the Model Employee Reinstatement for Ill-advised Termination (MERIT) Act to reinstate federal employees who were unjustly fired by Donald Trump and Elon Musks DOGE initiative that targeted federal workers. In addition to rehiring these workers, the MERIT Act gives them the back pay they deserve. Lobbied in support of H.R. 492 and S. 134, the Saving the Civil Service Act to prevent the politicization of the non-partisan civil service by limiting the conversion of federal jobs from the competitive service to the excepted service without congressional approval. Lobbied in support of H.R. 759 the Federal Firefighter's Families First Act to include mandatory overtime hours worked into the calculation of retirement benefits Lobbied in support of H.R. 1637 and S. 914 the Protect Veterans Jobs Act to reinstate veterans who were fired from their jobs a during the Trump Administration and DOGE purge of federal employees. Lobbied in support of H.R. 1989 the Protect Our Probationary Employees Act to ensure that if terminated probationary employees are reinstated, they will not need to restart their probationary period for the same job they previously held and can continue to do the important work of the American people. Lobbied in support of H.R. 2470 the COST of Relocations Act to require a cost-benefit analysis to be submitted to Congress to ensure that any attempt to move federal agencies is appropriately analyzed to guarantee it is in the best interest of the taxpayer and the agencys mission. Lobbied the House and Senate on H.R. 1 reconciliation opposing cuts to FERS and FEHB and changes to Title 5 workplace rules to pay for the bills tax cuts. Lobbied the House and Senate on H.R. 4, the Rescissions Act of 2025, to oppose rescissions to the U.S. Agency for International Development (USAID), the U.S. Department of State and the Corporation for Public Broadcasting. Lobbied House and Senate appropriators about FY26 appropriations. Lobbied the House and Senate on FY 2026 reconciliation opposing cuts to FERS and FEHB to pay for 2017 tax cuts. Lobbied against passage of H.R. 473, the "SHOW UP Act" and its provisions that would abrogate collective bargaining agreements. Lobbied against cutting services at federal agencies, pay and benefits of federal employees, Social Security and Medicare as a precondition of raising the debt ceiling. Lobbied in support of amendments to the House and Senate budget resolutions to restore collective bargaining rights. Lobbied on behalf of Social Security workforce on agency funding, the collective bargaining agreement, telework, and recruitment and retention benefits. Lobbied in support of H.R. 2086 and S. 997 the "Rights for the TSA Workforce Act to provide full title 5 collective bargaining rights for transportation security officers.
Client expense: $410,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2026 · second_quarter · Science/Technology
(H.R.8845/S.TBD) - FY2027 Commerce, Justice, Science, and Related Agencies Appropriations Act, Title I and Title III, all provisions related to research and education in NASA, NSF, NIST, and NOAA. (H.R.9022/S.TBD) - FY2027 Appropriations for Energy and Water Development, Title III - all provisions related to science and research, including nuclear physics research facilities. Full funding for the CHIPS and Science Act of 2022 (P.L. 117-167) - which re-authorized and re-designated the research missions of the National Science Foundation (NSF); spur domestic innovation of advanced technologies through basic and applied research; authorized new R&D programs across federal research agencies; and for other purposes. Proposals to protect university IP, including under potential Bayh-Dole "march in" rights, and mitigate nefarious influence from hostile foreign actors. S.854/H.R.1864 - Risky Research Review Act - whole bill, potential impact on bio-medical research, regulatory burden, and efforts to increase oversight and accountability. Proposed regulatory changes to Facilities and Administration (F&A) cost agreements/negotiated indirect cost reimbursements for federally sponsored research, including the proposed FAIR Model for indirect cost reimbursements. EOs, grant rescissions/cancellations, regulatory changes, and policy shifts that affect faculty, researchers, students, programs, and core research and education missions.
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Government Issues
Lobbied in support of H.R. 2550 / S. 2837, the Protect Americas Workforce Act to restore collective bargaining rights at several federal agencies, including several DHS agencies, including USCIS. Lobbied in support of Discharge Petition 6 that would make in order H.R. 2550 / S. 2837, the Protect American Workers Act to restore collective bargaining rights at several federal agencies. Lobbied against the nomination of Paul Ingrassia to head the Office of Special Counsel. Lobbied against the nomination Charles Arrington to serve on the Federal Labor Relations Authority. Lobbied against S. 854, Risky Research Review Act Lobbied in support of S. 572, Shadow Wolves Improvement Act Lobbied in opposition to H.R. 1210, the Protecting Taxpayers Wallet Act Lobbied in opposition to H.R. 2249, the Preserving Presidential Management Authority Act Lobbied in opposition to H.R. 2174, the Paycheck Protection Act Lobbied against the confirmation of Scott Kupur to be the director of the Office of Management and Budget Lobbied against the confirmation of Eric M. Ueland to be Deputy Director for Management, Office of Management and Budget Lobbied in support of H.R. 493 and S. 126 the Federal Adjustment of Income Rates Act Lobbied in support of the "DC Admissions Act," H.R. 51 and S. 51 to make the D.C. a state. Lobbied in support of passage of S. 1077 to prevent massive budget cuts to D.C. budget Lobbied in support of H.R. 491, the "Equal COLA Act" for Federal Employee Retirement System beneficiaries' cost-of-living adjustment to be the same as Civil Service Retirement System benefits rather than arbitrarily cut by one full percentage point. Lobbied in support of H.R. 1835 the Model Employee Reinstatement for Ill-advised Termination (MERIT) Act to reinstate federal employees who were unjustly fired by Donald Trump and Elon Musks DOGE initiative that targeted federal workers. In addition to rehiring these workers, the MERIT Act gives them the back pay they deserve. Lobbied in support of H.R. 492 and S. 134, the Saving the Civil Service Act to prevent the politicization of the non-partisan civil service by limiting the conversion of federal jobs from the competitive service to the excepted service without congressional approval. Lobbied in support of H.R. 759 the Federal Firefighter's Families First Act to include mandatory overtime hours worked into the calculation of retirement benefits Lobbied in support of H.R. 1637 and S. 914 the Protect Veterans Jobs Act to reinstate veterans who were fired from their jobs a during the Trump Administration and DOGE purge of federal employees. Lobbied in support of H.R. 1989 the Protect Our Probationary Employees Act to ensure that if terminated probationary employees are reinstated, they will not need to restart their probationary period for the same job they previously held and can continue to do the important work of the American people. Lobbied in support of H.R. 2470 the COST of Relocations Act to require a cost-benefit analysis to be submitted to Congress to ensure that any attempt to move federal agencies is appropriately analyzed to guarantee it is in the best interest of the taxpayer and the agencys mission. Lobbied the House and Senate on H.R. 1 reconciliation opposing cuts to FERS and FEHB and changes to Title 5 workplace rules to pay for the bills tax cuts. Lobbied the House and Senate on H.R. 4, the Rescissions Act of 2025, to oppose rescissions to the U.S. Agency for International Development (USAID), the U.S. Department of State and the Corporation for Public Broadcasting. Lobbied House and Senate appropriators about FY26 appropriations. Lobbied the House and Senate on FY 2026 reconciliation opposing cuts to FERS and FEHB to pay for 2017 tax cuts. Lobbied against passage of H.R. 473, the "SHOW UP Act" and its provisions that would abrogate collective bargaining agreements. Lobbied against cutting services at federal agencies, pay and benefits of federal employees, Social Security and Medicare as a precondition of raising the debt ceiling. Lobbied in support of amendments to the House and Senate budget resolutions to restore collective bargaining rights. Lobbied on behalf of Social Security workforce on agency funding, the collective bargaining agreement, telework, and recruitment and retention benefits. Lobbied in support of H.R. 2086 and S. 997 the "Rights for the TSA Workforce Act to provide full title 5 collective bargaining rights for transportation security officers.
Client expense: $390,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2026 · second_quarter · Science/Technology
Proposed cap of 15% on F&A expenditures (NIH, NSF, DoD, DOE) and the FAIR Model as the proposed alternative developed by a group of Subject Matter Experts as well as higher education and research advocacy associations Updates on impacts of Executive Orders and agency directives on U-M operations and funded research projects CREATE AI Act of 2025 (H.R. 2385) Deterrent Act (H.R. 1048) Risky Research Review Act (S. 854/H.R. 1864) Investing in National Next-Generation Opportunities for Venture Acceleration and Technological Excellence (INNOVATE) Act (S. 853) SBIR/STTR reauthorization - potential provisions related to undue foreign influence Policy related to AI research and funding, including the Department of Energy Genesis Mission Issues pertaining to science and security National Defense Authorization Act for FY26 (NDAA) H.R. 881 - DHS Restrictions on Confucius Institutes and Chinese Entities of Concern Act H.R. 1082 - Cell and Tissue Product Safety Securing American Funding and Expertise from Adversarial Research Exploitation Act of 2025 BIOSECURE Act SAFE Research Act Discussion of proposals that would impact the Bayh-Dole Act, including related impact on university technology transfer programs, and university licensing revenue Proposed revisions to 2 CFR Part 200 (Uniform Guidance)
Client expense: $150,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), SENATE
2026 · second_quarter · Science/Technology
Monitored and advised on Artificial Intelligence; Monitored S.854/H.R. 1864 - Risky Research Review Act; Monitored H.R. 1048/S.1296 - the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act; Monitored and advised on H.R. 9102, the Biotech Investment National Security Act of 2026.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medical/Disease Research/Clinical Labs
Issue: Educate Congress and the administration about the impact of regulatory burden on medical research. Issue: Oppose inappropriate use of march-in authority. Issue: Educate Congress and the administration about opportunities to strengthen medical research supported by National Institutes of Health (NIH). H.R.1864/S.854 - Risky Research Review Act Issue: Support prevention of unintended consequences from new restrictions on life sciences research. H.R.1863/S.855 - Royalty Transparency Act Issue: Support efforts to ensure the National Institutes of Health (NIH) peer review system is not hampered. Issue: Avoid unnecessary restrictions on types of research including human embryonic stem cell, fetal tissue, gain of function, and animal research. H.Res.708 - Recognizing the contributions of medical research and observing "Medical Research Week" from September 15 through September 19, 2025. Issue: Educate Congress about the importance of NIH-supported medical research. P.L.119-60 - National Defense Authorization Act for Fiscal Year 2026 H.R.3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 S.1071 - National Defense Authorization Act for Fiscal Year 2026 Issue: Provide comments on provisions to strengthen research, including rejecting inclusion of subtitle D, SAFE Research Act.
Client expense: $821,438 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
2026 · second_quarter · Science/Technology
Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235); Cloud Labs to Advance Biotechnology Act of 2025 (S. 2676);
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Science/Technology
(H.R.TBD/S.TBD) - FY2027 Commerce, Justice, Science, and Related Agencies Appropriations Act, Title I and Title III, all provisions related to research and education in NASA, NSF, NIST, and NOAA. (H.R.TBD/S.TBD) - FY2027 Appropriations for Energy and Water Development, Title III - all provisions related to science and research, including nuclear physics research facilities. Full funding for the CHIPS and Science Act of 2022 (P.L. 117-167) - which re-authorized and re-designated the research missions of the National Science Foundation (NSF); spur domestic innovation of advanced technologies through basic and applied research; authorized new R&D programs across federal research agencies; and for other purposes. Proposals to protect university IP, including under potential Bayh-Dole "march in" rights, and mitigate nefarious influence from hostile foreign actors. S.854 - Risky Research Review Act - whole bill, potential impact on bio-medical research, regulatory burden, and efforts to increase oversight and accountability. Proposed regulatory changes to Facilities and Administration (F&A) cost agreements/negotiated indirect cost reimbursements for federally sponsored research, including the proposed FAIR Model for indirect cost reimbursements. EOs, grant rescissions/cancellations, regulatory changes, and policy shifts that affect faculty, researchers, students, programs, and core research and education missions.
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Government Issues
Lobbied in support of H.R. 2550 / S. 2837, the Protect Americas Workforce Act to restore collective bargaining rights at several federal agencies, including several DHS agencies, including USCIS. Lobbied in support of Discharge Petition 6 that would make in order H.R. 2550 / S. 2837, the Protect American Workers Act to restore collective bargaining rights at several federal agencies. Lobbied against the nomination of Paul Ingrassia to head the Office of Special Counsel. Lobbied against the nomination Charles Arrington to serve on the Federal Labor Relations Authority. Lobbied against S. 854, Risky Research Review Act Lobbied in support of S. 572, Shadow Wolves Improvement Act Lobbied in opposition to H.R. 1210, the Protecting Taxpayers Wallet Act Lobbied in opposition to H.R. 2249, the Preserving Presidential Management Authority Act Lobbied in opposition to H.R. 2174, the Paycheck Protection Act Lobbied against the confirmation of Scott Kupur to be the director of the Office of Management and Budget Lobbied against the confirmation of Eric M. Ueland to be Deputy Director for Management, Office of Management and Budget Lobbied in support of H.R. 493 and S. 126 the Federal Adjustment of Income Rates Act Lobbied in support of the "DC Admissions Act," H.R. 51 and S. 51 to make the D.C. a state. Lobbied in support of passage of S. 1077 to prevent massive budget cuts to D.C. budget Lobbied in support of H.R. 491, the "Equal COLA Act" for Federal Employee Retirement System beneficiaries' cost-of-living adjustment to be the same as Civil Service Retirement System benefits rather than arbitrarily cut by one full percentage point. Lobbied in support of H.R. 1835 the Model Employee Reinstatement for Ill-advised Termination (MERIT) Act to reinstate federal employees who were unjustly fired by Donald Trump and Elon Musks DOGE initiative that targeted federal workers. In addition to rehiring these workers, the MERIT Act gives them the back pay they deserve. Lobbied in support of H.R. 492 and S. 134, the Saving the Civil Service Act to prevent the politicization of the non-partisan civil service by limiting the conversion of federal jobs from the competitive service to the excepted service without congressional approval. Lobbied in support of H.R. 759 the Federal Firefighter's Families First Act to include mandatory overtime hours worked into the calculation of retirement benefits Lobbied in support of H.R. 1637 and S. 914 the Protect Veterans Jobs Act to reinstate veterans who were fired from their jobs a during the Trump Administration and DOGE purge of federal employees. Lobbied in support of H.R. 1989 the Protect Our Probationary Employees Act to ensure that if terminated probationary employees are reinstated, they will not need to restart their probationary period for the same job they previously held and can continue to do the important work of the American people. Lobbied in support of H.R. 2470 the COST of Relocations Act to require a cost-benefit analysis to be submitted to Congress to ensure that any attempt to move federal agencies is appropriately analyzed to guarantee it is in the best interest of the taxpayer and the agencys mission. Lobbied the House and Senate on H.R. 1 reconciliation opposing cuts to FERS and FEHB and changes to Title 5 workplace rules to pay for the bills tax cuts. Lobbied the House and Senate on H.R. 4, the Rescissions Act of 2025, to oppose rescissions to the U.S. Agency for International Development (USAID), the U.S. Department of State and the Corporation for Public Broadcasting. Lobbied House and Senate appropriators about FY26 appropriations. Lobbied the House and Senate on FY 2026 reconciliation opposing cuts to FERS and FEHB to pay for 2017 tax cuts. Lobbied against passage of H.R. 473, the "SHOW UP Act" and its provisions that would abrogate collective bargaining agreements. Lobbied against cutting services at federal agencies, pay and benefits of federal employees, Social Security and Medicare as a precondition of raising the debt ceiling. Lobbied in support of amendments to the House and Senate budget resolutions to restore collective bargaining rights. Lobbied on behalf of Social Security workforce on agency funding, the collective bargaining agreement, telework, and recruitment and retention benefits. Lobbied in support of H.R. 2086 and S. 997 the "Rights for the TSA Workforce Act to provide full title 5 collective bargaining rights for transportation security officers.
Client expense: $410,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2026 · first_quarter · Science/Technology
Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235); Cloud Labs to Advance Biotechnology Act of 2025 (S. 2676);
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Science/Technology
Proposed cap of 15% on F&A expenditures (NIH, NSF, DoD, DOE) and the FAIR Model as the proposed alternative developed by a group of Subject Matter Experts as well as higher education and research advocacy associations Updates on impacts of Executive Orders and agency directives on U-M operations and funded research projects CREATE AI Act of 2025 (H.R. 2385) Deterrent Act (H.R. 1048) Risky Research Review Act (S. 854/H.R. 1864) Investing in National Next-Generation Opportunities for Venture Acceleration and Technological Excellence (INNOVATE) Act (S. 853) SBIR/STTR reauthorization - potential provisions related to undue foreign influence Policy related to AI research and funding, including the Department of Energy Genesis Mission Issues pertaining to science and security National Defense Authorization Act for FY26 (NDAA) H.R. 881 - DHS Restrictions on Confucius Institutes and Chinese Entities of Concern Act H.R. 1082 - Cell and Tissue Product Safety Securing American Funding and Expertise from Adversarial Research Exploitation Act of 2025 BIOSECURE Act SAFE Research Act Discussion of proposals that would impact the Bayh-Dole Act, including related impact on university technology transfer programs, and university licensing revenue
Client expense: $190,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), SENATE
2026 · first_quarter · Medical/Disease Research/Clinical Labs
Issue: Educate Congress and the administration about the impact of regulatory burden on medical research. Issue: Oppose inappropriate use of march-in authority. Issue: Educate Congress and the administration about opportunities to strengthen medical research supported by National Institutes of Health (NIH). H.R.1864/S.854 - Risky Research Review Act Issue: Support prevention of unintended consequences from new restrictions on life sciences research. H.R.1863/S.855 - Royalty Transparency Act Issue: Support efforts to ensure the National Institutes of Health (NIH) peer review system is not hampered. H.Res.708 - Recognizing the contributions of medical research and observing "Medical Research Week" from September 15 through September 19, 2025. Issue: Educate Congress about the importance of NIH-supported medical research. P.L.119-60 - National Defense Authorization Act for Fiscal Year 2026 H.R.3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 S.1071 - National Defense Authorization Act for Fiscal Year 2026 Issue: Provide comments on provisions to strengthen research, including rejecting inclusion of subtitle D, SAFE Research Act.
Client expense: $577,720 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
2026 · first_quarter · Science/Technology
Monitored and advised on Artificial Intelligence; S.854/H.R. 1864 - Risky Research Review Act; H.R. 1048/S.1296 - the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Government Issues
Lobbied in support of H.R. 2550 / S. 2837, the Protect Americas Workforce Act to restore collective bargaining rights at several federal agencies, including several DHS agencies, including USCIS. Lobbied in support of Discharge Petition 6 that would make in order H.R. 2550 / S. 2837, the Protect American Workers Act to restore collective bargaining rights at several federal agencies. Lobbied against the nomination of Paul Ingrassia to head the Office of Special Counsel. Lobbied against the nomination Charles Arrington to serve on the Federal Labor Relations Authority. Lobbied against S. 854, Risky Research Review Act Lobbied in support of S. 572, Shadow Wolves Improvement Act Lobbied in opposition to H.R. 1210, the Protecting Taxpayers Wallet Act Lobbied in opposition to H.R. 2249, the Preserving Presidential Management Authority Act Lobbied in opposition to H.R. 2174, the Paycheck Protection Act Lobbied against the confirmation of Scott Kupur to be the director of the Office of Management and Budget Lobbied against the confirmation of Eric M. Ueland to be Deputy Director for Management, Office of Management and Budget Lobbied in support of H.R. 493 and S. 126 the Federal Adjustment of Income Rates Act Lobbied in support of the "DC Admissions Act," H.R. 51 and S. 51 to make the D.C. a state. Lobbied in support of passage of S. 1077 to prevent massive budget cuts to D.C. budget Lobbied in support of H.R. 491, the "Equal COLA Act" for Federal Employee Retirement System beneficiaries' cost-of-living adjustment to be the same as Civil Service Retirement System benefits rather than arbitrarily cut by one full percentage point. Lobbied in support of H.R. 1835 the Model Employee Reinstatement for Ill-advised Termination (MERIT) Act to reinstate federal employees who were unjustly fired by Donald Trump and Elon Musks DOGE initiative that targeted federal workers. In addition to rehiring these workers, the MERIT Act gives them the back pay they deserve. Lobbied in support of H.R. 492 and S. 134, the Saving the Civil Service Act to prevent the politicization of the non-partisan civil service by limiting the conversion of federal jobs from the competitive service to the excepted service without congressional approval. Lobbied in support of H.R. 759 the Federal Firefighter's Families First Act to include mandatory overtime hours worked into the calculation of retirement benefits Lobbied in support of H.R. 1637 and S. 914 the Protect Veterans Jobs Act to reinstate veterans who were fired from their jobs a during the Trump Administration and DOGE purge of federal employees. Lobbied in support of H.R. 1989 the Protect Our Probationary Employees Act to ensure that if terminated probationary employees are reinstated, they will not need to restart their probationary period for the same job they previously held and can continue to do the important work of the American people. Lobbied in support of H.R. 2470 the COST of Relocations Act to require a cost-benefit analysis to be submitted to Congress to ensure that any attempt to move federal agencies is appropriately analyzed to guarantee it is in the best interest of the taxpayer and the agencys mission. Lobbied the House and Senate on H.R. 1 reconciliation opposing cuts to FERS and FEHB and changes to Title 5 workplace rules to pay for the bills tax cuts. Lobbied the House and Senate on H.R. 4, the Rescissions Act of 2025, to oppose rescissions to the U.S. Agency for International Development (USAID), the U.S. Department of State and the Corporation for Public Broadcasting. Lobbied House and Senate appropriators about FY26 appropriations. Lobbied the House and Senate on FY 2026 reconciliation opposing cuts to FERS and FEHB to pay for 2017 tax cuts. Lobbied against passage of H.R. 473, the "SHOW UP Act" and its provisions that would abrogate collective bargaining agreements. Lobbied against cutting services at federal agencies, pay and benefits of federal employees, Social Security and Medicare as a precondition of raising the debt ceiling. Lobbied in support of amendments to the House and Senate budget resolutions to restore collective bargaining rights. Lobbied on behalf of Social Security workforce on agency funding, the collective bargaining agreement, telework, and recruitment and retention benefits. Lobbied in support of H.R. 2086 and S. 997 the "Rights for the TSA Workforce Act to provide full title 5 collective bargaining rights for transportation security officers
Client expense: $360,191 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2025 · fourth_quarter · Government Issues
Lobbied in support of H.R. 2550 / S. 2837, the Protect Americas Workforce Act to restore collective bargaining rights at several federal agencies, including several DHS agencies, including USCIS. Lobbied in support of Discharge Petition 6 that would make in order H.R. 2550 / S. 2837, the Protect American Workers Act to restore collective bargaining rights at several federal agencies. Lobbied against the nomination of Paul Ingrassia to head the Office of Special Counsel. Lobbied against the nomination Charles Arrington to serve on the Federal Labor Relations Authority. Lobbied against S. 854, Risky Research Review Act Lobbied in support of S. 572, Shadow Wolves Improvement Act Lobbied in opposition to H.R. 1210, the Protecting Taxpayers Wallet Act Lobbied in opposition to H.R. 2249, the Preserving Presidential Management Authority Act Lobbied in opposition to H.R. 2174, the Paycheck Protection Act Lobbied against the confirmation of Scott Kupur to be the director of the Office of Management and Budget Lobbied against the confirmation of Eric M. Ueland to be Deputy Director for Management, Office of Management and Budget Lobbied in support of H.R. 493 and S. 126 the Federal Adjustment of Income Rates Act Lobbied in support of the "DC Admissions Act," H.R. 51 and S. 51 to make the D.C. a state. Lobbied in support of passage of S. 1077 to prevent massive budget cuts to D.C. budget Lobbied in support of H.R. 491, the "Equal COLA Act" for Federal Employee Retirement System beneficiaries' cost-of-living adjustment to be the same as Civil Service Retirement System benefits rather than arbitrarily cut by one full percentage point. Lobbied in support of H.R. 1835 the Model Employee Reinstatement for Ill-advised Termination (MERIT) Act to reinstate federal employees who were unjustly fired by Donald Trump and Elon Musks DOGE initiative that targeted federal workers. In addition to rehiring these workers, the MERIT Act gives them the back pay they deserve. Lobbied in support of H.R. 492 and S. 134, the Saving the Civil Service Act to prevent the politicization of the non-partisan civil service by limiting the conversion of federal jobs from the competitive service to the excepted service without congressional approval. Lobbied in support of H.R. 759 the Federal Firefighter's Families First Act to include mandatory overtime hours worked into the calculation of retirement benefits Lobbied in support of H.R. 1637 and S. 914 the Protect Veterans Jobs Act to reinstate veterans who were fired from their jobs a during the Trump Administration and DOGE purge of federal employees. Lobbied in support of H.R. 1989 the Protect Our Probationary Employees Act to ensure that if terminated probationary employees are reinstated, they will not need to restart their probationary period for the same job they previously held and can continue to do the important work of the American people. Lobbied in support of H.R. 2470 the COST of Relocations Act to require a cost-benefit analysis to be submitted to Congress to ensure that any attempt to move federal agencies is appropriately analyzed to guarantee it is in the best interest of the taxpayer and the agencys mission. Lobbied the House and Senate on H.R. 1 reconciliation opposing cuts to FERS and FEHB and changes to Title 5 workplace rules to pay for the bills tax cuts. Lobbied the House and Senate on H.R. 4, the Rescissions Act of 2025, to oppose rescissions to the U.S. Agency for International Development (USAID), the U.S. Department of State and the Corporation for Public Broadcasting. Lobbied House and Senate appropriators about FY26 appropriations. Lobbied the House and Senate on FY 2026 reconciliation opposing cuts to FERS and FEHB to pay for 2017 tax cuts. Lobbied against passage of H.R. 473, the "SHOW UP Act" and its provisions that would abrogate collective bargaining agreements. Lobbied against cutting services at federal agencies, pay and benefits of federal employees, Social Security and Medicare as a precondition of raising the debt ceiling. Lobbied in support of amendments to the House and Senate budget resolutions to restore collective bargaining rights. Lobbied on behalf of Social Security workforce on agency funding, the collective bargaining agreement, telework, and recruitment and retention benefits. Lobbied in support of H.R. 2086 and S. 997 the "Rights for the TSA Workforce Act to provide full title 5 collective bargaining rights for transportation security officers
Client expense: $45,800 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2025 · third_quarter · Government Issues
Lobbied in support of H.R. 2550 / S. 2837, the Protect Americas Workforce Act to restore collective bargaining rights at several federal agencies, including several DHS agencies, including USCIS. Lobbied in support of Discharge Petition 6 that would make in order H.R. 2550 / S. 2837, the Protect American Workers Act to restore collective bargaining rights at several federal agencies. Lobbied against the nomination of Paul Ingrassia to head the Office of Special Counsel. Lobbied against the nomination Charles Arrington to serve on the Federal Labor Relations Authority. Lobbied against S. 854, Risky Research Review Act Lobbied in support of S. 572, Shadow Wolves Improvement Act Lobbied in opposition to H.R. 1210, the Protecting Taxpayers Wallet Act Lobbied in opposition to H.R. 2249, the Preserving Presidential Management Authority Act Lobbied in opposition to H.R. 2174, the Paycheck Protection Act Lobbied against the confirmation of Scott Kupur to be the director of the Office of Management and Budget Lobbied against the confirmation of Eric M. Ueland to be Deputy Director for Management, Office of Management and Budget Lobbied in support of H.R. 493 and S. 126 the Federal Adjustment of Income Rates Act Lobbied in support of the "DC Admissions Act," H.R. 51 and S. 51 to make the D.C. a state. Lobbied in support of passage of S. 1077 to prevent massive budget cuts to D.C. budget Lobbied in support of H.R. 491, the "Equal COLA Act" for Federal Employee Retirement System beneficiaries' cost-of-living adjustment to be the same as Civil Service Retirement System benefits rather than arbitrarily cut by one full percentage point. Lobbied in support of H.R. 1835 the Model Employee Reinstatement for Ill-advised Termination (MERIT) Act to reinstate federal employees who were unjustly fired by Donald Trump and Elon Musks DOGE initiative that targeted federal workers. In addition to rehiring these workers, the MERIT Act gives them the back pay they deserve. Lobbied in support of H.R. 492 and S. 134, the Saving the Civil Service Act to prevent the politicization of the non-partisan civil service by limiting the conversion of federal jobs from the competitive service to the excepted service without congressional approval. Lobbied in support of H.R. 759 the Federal Firefighter's Families First Act to include mandatory overtime hours worked into the calculation of retirement benefits Lobbied in support of H.R. 1637 and S. 914 the Protect Veterans Jobs Act to reinstate veterans who were fired from their jobs a during the Trump Administration and DOGE purge of federal employees. Lobbied in support of H.R. 1989 the Protect Our Probationary Employees Act to ensure that if terminated probationary employees are reinstated, they will not need to restart their probationary period for the same job they previously held and can continue to do the important work of the American people. Lobbied in support of H.R. 2470 the COST of Relocations Act to require a cost-benefit analysis to be submitted to Congress to ensure that any attempt to move federal agencies is appropriately analyzed to guarantee it is in the best interest of the taxpayer and the agencys mission. Lobbied the House and Senate on H.R. 1 reconciliation opposing cuts to FERS and FEHB and changes to Title 5 workplace rules to pay for the bills tax cuts. Lobbied the House and Senate on H.R. 4, the Rescissions Act of 2025, to oppose rescissions to the U.S. Agency for International Development (USAID), the U.S. Department of State and the Corporation for Public Broadcasting. Lobbied House and Senate appropriators about FY26 appropriations. Lobbied the House and Senate on FY 2026 reconciliation opposing cuts to FERS and FEHB to pay for 2017 tax cuts. Lobbied against passage of H.R. 473, the "SHOW UP Act" and its provisions that would abrogate collective bargaining agreements. Lobbied against cutting services at federal agencies, pay and benefits of federal employees, Social Security and Medicare as a precondition of raising the debt ceiling. Lobbied in support of amendments to the House and Senate budget resolutions to restore collective bargaining rights. Lobbied on behalf of Social Security workforce on agency funding, the collective bargaining agreement, telework, and recruitment and retention benefits. Lobbied in support of H.R. 2086 and S. 997 the "Rights for the TSA Workforce Act to provide full title 5 collective bargaining rights for transportation security officers
Client expense: $360,191 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2025 · fourth_quarter · Science/Technology
(H.R.5342/S.2354) - FY2026 Commerce, Justice, Science, and Related Agencies Appropriations Act, Title I and Title III, all provisions related to research and education in NASA, NSF, NIST, and NOAA. (H.R.4553/S.3293) - FY2026 Appropriations for Energy and Water Development, Title III - all provisions related to science and research, including nuclear physics research facilities. Full funding for the CHIPS and Science Act of 2022 (P.L. 117-167) - which re-authorized and re-designated the research missions of the National Science Foundation (NSF); spur domestic innovation of advanced technologies through basic and applied research; authorized new R&D programs across federal research agencies; and for other purposes. Proposals to protect university IP, including under potential Bayh-Dole "march in" rights, and mitigate nefarious influence from hostile foreign actors. S.854 - Risky Research Review Act - whole bill, potential impact on bio-medical research, regulatory burden, and efforts to increase oversight and accountability. Proposed regulatory changes to Facilities and Administration (F&A) cost agreements/negotiated indirect cost reimbursements for federally sponsored research, including the proposed FAIR Model for indirect cost reimbursements. EOs, grant rescissions/cancellations, regulatory changes, and policy shifts that affect faculty, researchers, students, programs, and core research and education missions.
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Government Issues
Lobbied in support of H.R. 2550 / S. 2837, the Protect Americas Workforce Act to restore collective bargaining rights at several federal agencies, including several DHS agencies, including USCIS. Lobbied in support of Discharge Petition 6 that would make in order H.R. 2550 / S. 2837, the Protect American Workers Act to restore collective bargaining rights at several federal agencies. Lobbied against the nomination of Paul Ingrassia to head the Office of Special Counsel. Lobbied against the nomination Charles Arrington to serve on the Federal Labor Relations Authority. Lobbied against S. 854, Risky Research Review Act Lobbied in support of S. 572, Shadow Wolves Improvement Act Lobbied in opposition to H.R. 1210, the Protecting Taxpayers Wallet Act Lobbied in opposition to H.R. 2249, the Preserving Presidential Management Authority Act Lobbied in opposition to H.R. 2174, the Paycheck Protection Act Lobbied against the confirmation of Scott Kupur to be the director of the Office of Management and Budget Lobbied against the confirmation of Eric M. Ueland to be Deputy Director for Management, Office of Management and Budget Lobbied in support of H.R. 493 and S. 126 the Federal Adjustment of Income Rates Act Lobbied in support of the "DC Admissions Act," H.R. 51 and S. 51 to make the D.C. a state. Lobbied in support of passage of S. 1077 to prevent massive budget cuts to D.C. budget Lobbied in support of H.R. 491, the "Equal COLA Act" for Federal Employee Retirement System beneficiaries' cost-of-living adjustment to be the same as Civil Service Retirement System benefits rather than arbitrarily cut by one full percentage point. Lobbied in support of H.R. 1835 the Model Employee Reinstatement for Ill-advised Termination (MERIT) Act to reinstate federal employees who were unjustly fired by Donald Trump and Elon Musks DOGE initiative that targeted federal workers. In addition to rehiring these workers, the MERIT Act gives them the back pay they deserve. Lobbied in support of H.R. 492 and S. 134, the Saving the Civil Service Act to prevent the politicization of the non-partisan civil service by limiting the conversion of federal jobs from the competitive service to the excepted service without congressional approval. Lobbied in support of H.R. 759 the Federal Firefighter's Families First Act to include mandatory overtime hours worked into the calculation of retirement benefits Lobbied in support of H.R. 1637 and S. 914 the Protect Veterans Jobs Act to reinstate veterans who were fired from their jobs a during the Trump Administration and DOGE purge of federal employees. Lobbied in support of H.R. 1989 the Protect Our Probationary Employees Act to ensure that if terminated probationary employees are reinstated, they will not need to restart their probationary period for the same job they previously held and can continue to do the important work of the American people. Lobbied in support of H.R. 2470 the COST of Relocations Act to require a cost-benefit analysis to be submitted to Congress to ensure that any attempt to move federal agencies is appropriately analyzed to guarantee it is in the best interest of the taxpayer and the agencys mission. Lobbied the House and Senate on H.R. 1 reconciliation opposing cuts to FERS and FEHB and changes to Title 5 workplace rules to pay for the bills tax cuts. Lobbied the House and Senate on H.R. 4, the Rescissions Act of 2025, to oppose rescissions to the U.S. Agency for International Development (USAID), the U.S. Department of State and the Corporation for Public Broadcasting. Lobbied House and Senate appropriators about FY26 appropriations. Lobbied the House and Senate on FY 2026 reconciliation opposing cuts to FERS and FEHB to pay for 2017 tax cuts. Lobbied against passage of H.R. 473, the "SHOW UP Act" and its provisions that would abrogate collective bargaining agreements. Lobbied against cutting services at federal agencies, pay and benefits of federal employees, Social Security and Medicare as a precondition of raising the debt ceiling. Lobbied in support of amendments to the House and Senate budget resolutions to restore collective bargaining rights. Lobbied on behalf of Social Security workforce on agency funding, the collective bargaining agreement, telework, and recruitment and retention benefits. Lobbied in support of H.R. 2086 and S. 997 the "Rights for the TSA Workforce Act to provide full title 5 collective bargaining rights for transportation security officers
Client expense: $450,426 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2025 · fourth_quarter · Science/Technology
Proposed cap of 15% on F&A expenditures (NIH, NSF, DoD, DOE) and the FAIR Model as the proposed alternative developed by a group of Subject Matter Experts as well as higher education and research advocacy associations Updates on impacts of Executive Orders and agency directives on U-M operations and funded research projects CREATE AI Act of 2025 (H.R. 2385) Deterrent Act (H.R. 1048) Risky Research Review Act (S. 854/H.R. 1864) Investing in National Next-Generation Opportunities for Venture Acceleration and Technological Excellence (INNOVATE) Act (S. 853) SBIR/STTR reauthorization - potential provisions related to undue foreign influence Policy related to AI research and funding Issues pertaining to science and security National Defense Authorization Act for FY26 (NDAA) H.R. 881 - DHS Restrictions on Confucius Institutes and Chinese Entities of Concern Act H.R. 1082 - Cell and Tissue Product Safety Securing American Funding and Expertise from Adversarial Research Exploitation Act of 2025 BIOSECURE Act SAFE Research Act Discussion of proposals that would impact the Bayh-Dole Act, including related impact on university technology transfer programs, and university licensing revenue
Client expense: $150,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), SENATE
2025 · fourth_quarter · Medical/Disease Research/Clinical Labs
Issue: Educate Congress and the administration about the impact of regulatory burden on medical research. Issue: Oppose inappropriate use of march-in authority. Issue: Educate Congress and the administration about opportunities to strengthen medical research supported by National Institutes of Health (NIH). H.R.1864/S.854 - Risky Research Review Act Issue: Support prevention of unintended consequences from new restrictions on life sciences research. H.R.1863/S.855 - Royalty Transparency Act Issue: Support efforts to ensure the National Institutes of Health (NIH) peer review system is not hampered. H.Res.708 - Recognizing the contributions of medical research and observing "Medical Research Week" from September 15 through September 19, 2025. Issue: Educate Congress about the importance of NIH-supported medical research. P.L.119-60 - National Defense Authorization Act for Fiscal Year 2026 H.R.3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 S.1071 - National Defense Authorization Act for Fiscal Year 2026 Issue: Provide comments on provisions to strengthen research, including rejecting inclusion of subtitle D, SAFE Research Act.
Client expense: $708,395 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
2025 · fourth_quarter · Science/Technology
Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235).
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Science/Technology
Monitored S.854 - Risky Research Review Act; H.R. 1048 - the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
2025 · third_quarter · Science/Technology
(H.R.5342/S.2354) - FY2026 Commerce, Justice, Science, and Related Agencies Appropriations Act, Title I and Title III, all provisions related to research and education in NASA, NSF, NIST, and NOAA. (H.R.4553/S.TBD) - FY2026 Appropriations for Energy and Water Development, Title III - all provisions related to science and research, including nuclear physics research facilities. Full funding for the CHIPS and Science Act of 2022 (P.L. 117-167) - which re-authorized and re-designated the research missions of the National Science Foundation (NSF); spur domestic innovation of advanced technologies through basic and applied research; authorized new R&D programs across federal research agencies; and for other purposes. Proposals to protect university IP, including under potential Bayh-Dole "march in" rights, and mitigate nefarious influence from hostile foreign actors. S.854 - Risky Research Review Act - whole bill, potential impact on bio-medical research, regulatory burden, and efforts to increase oversight and accountability. Proposed regulatory changes to Facilities and Administration (F&A) cost agreements/negotiated indirect cost reimbursements for federally sponsored research. EOs, grant rescissions/cancellations, regulatory changes, and policy shifts that affect faculty, researchers, students, programs, and core research and education missions.
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Science/Technology
NIH's proposed cap of 15% on F&A expenditures Updates on impacts of Executive Orders and agency directives on U-M operations and funded research projects CREATE AI Act of 2025 (H.R. 2385) Deterrent Act (H.R. 1048) Risky Research Review Act (S. 854/H.R. 1864) Investing in National Next-Generation Opportunities for Venture Acceleration and Technological Excellence (INNOVATE) Act (S. 853) SBIR/STTR reauthorization - potential provisions related to undue foreign influence Policy related to AI research and funding Issues pertaining to science and security National Defense Authorization Act for FY26 (NDAA) H.R. 881 - DHS Restrictions on Confucius Institutes and Chinese Entities of Concern Act H.R. 1082 - Cell and Tissue Product Safety Securing American Funding and Expertise from Adversarial Research Exploitation Act of 2025 BIOSECURE Act
Client expense: $160,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), SENATE
2025 · third_quarter · Government Issues
Lobbied in support of H.R. 2550 / S. 2837, the Protect Americas Workforce Act to restore collective bargaining rights at several federal agencies, including several DHS agencies, including USCIS. Lobbied in support of Discharge Petition 6 that would make in order H.R. 2550 / S. 2837, the Protect American Workers Act to restore collective bargaining rights at several federal agencies. Lobbied against the nomination of Paul Ingrassia to head the Office of Special Counsel. Lobbied against the nomination Charles Arrington to serve on the Federal Labor Relations Authority. Lobbied against S. 854, Risky Research Review Act Lobbied in support of S. 572, Shadow Wolves Improvement Act Lobbied in opposition to H.R. 1210, the Protecting Taxpayers Wallet Act Lobbied in opposition to H.R. 2249, the Preserving Presidential Management Authority Act Lobbied in opposition to H.R. 2174, the Paycheck Protection Act Lobbied against the confirmation of Scott Kupur to be the director of the Office of Management and Budget Lobbied against the confirmation of Eric M. Ueland to be Deputy Director for Management, Office of Management and Budget Lobbied in support of H.R. 493 and S. 126 the Federal Adjustment of Income Rates Act Lobbied in support of the "DC Admissions Act," H.R. 51 and S. 51 to make the D.C. a state. Lobbied in support of passage of S. 1077 to prevent massive budget cuts to D.C. budget Lobbied in support of H.R. 491, the "Equal COLA Act" for Federal Employee Retirement System beneficiaries' cost-of-living adjustment to be the same as Civil Service Retirement System benefits rather than arbitrarily cut by one full percentage point. Lobbied in support of H.R. 1835 the Model Employee Reinstatement for Ill-advised Termination (MERIT) Act to reinstate federal employees who were unjustly fired by Donald Trump and Elon Musks DOGE initiative that targeted federal workers. In addition to rehiring these workers, the MERIT Act gives them the back pay they deserve. Lobbied in support of H.R. 492 and S. 134, the Saving the Civil Service Act to prevent the politicization of the non-partisan civil service by limiting the conversion of federal jobs from the competitive service to the excepted service without congressional approval. Lobbied in support of H.R. 759 the Federal Firefighter's Families First Act to include mandatory overtime hours worked into the calculation of retirement benefits Lobbied in support of H.R. 1637 and S. 914 the Protect Veterans Jobs Act to reinstate veterans who were fired from their jobs a during the Trump Administration and DOGE purge of federal employees. Lobbied in support of H.R. 1989 the Protect Our Probationary Employees Act to ensure that if terminated probationary employees are reinstated, they will not need to restart their probationary period for the same job they previously held and can continue to do the important work of the American people. Lobbied in support of H.R. 2470 the COST of Relocations Act to require a cost-benefit analysis to be submitted to Congress to ensure that any attempt to move federal agencies is appropriately analyzed to guarantee it is in the best interest of the taxpayer and the agencys mission. Lobbied the House and Senate on H.R. 1 reconciliation opposing cuts to FERS and FEHB and changes to Title 5 workplace rules to pay for the bills tax cuts. Lobbied the House and Senate on H.R. 4, the Rescissions Act of 2025, to oppose rescissions to the U.S. Agency for International Development (USAID), the U.S. Department of State and the Corporation for Public Broadcasting. Lobbied House and Senate appropriators about FY26 appropriations. Lobbied the House and Senate on FY 2026 reconciliation opposing cuts to FERS and FEHB to pay for 2017 tax cuts. Lobbied against passage of H.R. 473, the "SHOW UP Act" and its provisions that would abrogate collective bargaining agreements. Lobbied against cutting services at federal agencies, pay and benefits of federal employees, Social Security and Medicare as a precondition of raising the debt ceiling. Lobbied in support of amendments to the House and Senate budget resolutions to restore collective bargaining rights. Lobbied on behalf of Social Security workforce on agency funding, the collective bargaining agreement, telework, and recruitment and retention benefits. Lobbied in support of H.R. 2086 and S. 997 the "Rights for the TSA Workforce Act to provide full title 5 collective bargaining rights for transportation security officers
Client expense: $360,191 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2025 · third_quarter · Medical/Disease Research/Clinical Labs
Issue: Educate Congress and the administration about the impact of regulatory burden on medical research. Issue: Oppose inappropriate use of march-in authority. Issue: Educate Congress and the administration about opportunities to strengthen medical research supported by National Institutes of Health (NIH). H.R.1864/S.854 - Risky Research Review Act Issue: Support prevention of unintended consequences from new restrictions on life sciences research. H.R.1863/S.855 - Royalty Transparency Act Issue: Ensure bill does not hamper the National Institutes of Health (NIH) peer review system. H.Res.708 - Recognizing the contributions of medical research and observing "Medical Research Week" from September 15 through September 19, 2025. Issue: Educate Congress about the importance of NIH-supported medical research.
Client expense: $758,175 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
2025 · third_quarter · Science/Technology
Monitored S.854 - Risky Research Review Act and H.R. 1048 - the Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Science/Technology
Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235).
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Science/Technology
H.R. 1864 and S. 854: Risky Research Review Act A bill to amend title 31, United States Code, to establish the Life Sciences Research Security Board, and for other purposes (ALL). Presidential and executive actions to cap Facilities and Administrative (F&A) costs for research. Presidential and executive actions to freeze or terminate federal research grants. Presidential and executive actions to pause scientific research agency communications and meetings.
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Government Issues
Lobbied the House and Senate on H.R. 1 reconciliation opposing cuts to FERS and FEHB and changes to Title 5 workplace rules to pay for the bills tax cuts. Lobbied the House and Senate on H.R. 4, the Rescissions Act of 2025, to oppose rescissions to the U.S. Agency for International Development (USAID), the U.S. Department of State and the Corporation for Public Broadcasting. Lobbied House and Senate appropriators about FY26 appropriations. Lobbied in support of Discharge Petition 6 that would make in order H.R. 2550, the Protect American Workers Act to restore collective bargaining rights at several federal agencies. Lobbied against the nomination of Paul Ingrassia to head the Office of Special Counsel. Lobbied against the nomination Charles Arrington to serve on the Federal Labor Relations Authority. Lobbied against S. 854, Risky Research Review Act. Lobbied in support of S. 572, Shadow Wolves Improvement Act. Lobbied against the confirmation of Scott Kupor to be the director of the Office of Personnel Management. Lobbied against the confirmation of Eric M. Ueland to be Deputy Director for Management, Office of Management and Budget. Lobbied in support of H.R. 2550 (and lobbied for the introduction of a Senate companion), the Protect Americas Workforce Act to rescind the Trump Executive Order eliminating federal collective bargaining rights at several federal agencies. Lobbied the House and Senate on FY 2026 reconciliation opposing cuts to FERS and FEHB to pay for 2017 tax cuts. Lobbied against passage of H.R. 473, the "SHOW UP Act" and its provisions that would abrogate collective bargaining agreements. Lobbied in support of H.R. 493 and S. 126 the Federal Adjustment of Income Rates Act Lobbied against cutting services at federal agencies, pay and benefits of federal employees, Social Security and Medicare as a precondition of raising the debt ceiling. Lobbied in support of the "DC Admissions Act," H.R. 51 and S. 51 to make the D.C. a state. Lobbied in support of passage of S. 1077 to prevent massive budget cuts to D.C. budget. Lobbied in support of amendments to the House and Senate budget resolutions to restore collective bargaining rights. Lobbied in support of H.R. 491/S. 624, the "Equal COLA Act" for Federal Employee Retirement System beneficiaries' cost-of-living adjustment to be the same as Civil Service Retirement System benefits rather than arbitrarily cut by one full percentage point. Lobbied on behalf of Social Security workforce on agency funding, the collective bargaining agreement, telework, and recruitment and retention benefits. Lobbied in support of H.R. 2086 and S. 997 the "Rights for the TSA Workforce Act to provide full title 5 collective bargaining rights for transportation security officers. Lobbied in support of H.R. 1835 the Model Employee Reinstatement for Ill-advised Termination (MERIT) Act to reinstate and provide back pay to probationary federal employees who were unjustly fired in 2025. Lobbied in support of H.R. 492 and S. 134, the Saving the Civil Service Act to prevent the politicization of the non-partisan civil service by limiting the conversion of federal jobs from the competitive service to the excepted service without congressional approval. Lobbied in support of H.R. 759 the Federal Firefighter's Families First Act to include mandatory overtime hours worked into the calculation of retirement benefits. Lobbied in support of H.R. 1637 and S. 914 the Protect Veterans Jobs Act to reinstate veterans who were fired from their jobs a during the Trump Administration and DOGE purge of federal employees. Lobbied in support of H.R. 1989 the Protect Our Probationary Employees Act to ensure that if terminated probationary employees are reinstated, they will not need to restart their probationary period for the same job they previously held and can continue to do the important work of the American people. Lobbied in support of H.R. 2470 the COST of Relocations Act to require a cost-benefit analysis to be submitted to Congress to ensure that any attempt to move federal agencies is appropriately analyzed to guarantee it is in the best interest of the taxpayer and the agencys mission. Lobbied in opposition to H.R. 1210/S. 511, the Protecting Taxpayers Wallet Act Lobbied in opposition to H.R. 2249, the Preserving Presidential Management Authority Act Lobbied in opposition to H.R. 2174/S. 1597, the Paycheck Protection Act
Client expense: $590,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2025 · second_quarter · Science/Technology
(H.R.TBD/S.2354) - FY2026 Commerce, Justice, Science, and Related Agencies Appropriations Act, Title I and Title III, all provisions related to research and education in NASA, NSF, NIST, and NOAA. (H.R.TBD/S.TBD) - FY2026 Appropriations for Energy and Water Development, Title III - all provisions related to science and research, including nuclear physics research facilities. Full funding for the CHIPS and Science Act of 2022 (P.L. 117-167) - which re-authorized and re-designated the research missions of the National Science Foundation (NSF); spur domestic innovation of advanced technologies through basic and applied research; authorized new R&D programs across federal research agencies; and for other purposes. Proposals to protect university IP, including under potential Bayh-Dole "march in" rights, and mitigate nefarious influence from hostile foreign actors. S.854 - Risky Research Review Act - whole bill, potential impact on bio-medical research, regulatory burden, and efforts to increase oversight and accountability. Proposed regulatory changes to Facilities and Administration (F&A) cost agreements/negotiated indirect cost reimbursements for federally sponsored research. EOs, grant rescissions/cancellations, regulatory changes, and policy shifts that affect faculty, researchers, students, programs, and core research and education missions.
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Science/Technology
NIH's proposed cap of 15% on F&A expenditures Updates on impacts of Executive Orders and agency directives on U-M operations and funded research projects CREATE AI Act of 2025 (H.R. 2385) Deterrent Act (H.R. 1048) Risky Research Review Act (S. 854/H.R. 1864) Investing in National Next-Generation Opportunities for Venture Acceleration and Technological Excellence (INNOVATE) Act (S. 853) SBIR/STTR reauthorization - potential provisions related to undue foreign influence Policy related to AI research and funding Issues pertaining to science and security National Defense Authorization Act for FY26 (NDAA) H.R. 881 - DHS Restrictions on Confucius Institutes and Chinese Entities of Concern Act H.R. 1082 - Cell and Tissue Product Safety
Client expense: $110,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), SENATE
2025 · second_quarter · Medical/Disease Research/Clinical Labs
Issue: Educate Congress and the administration about the impact of regulatory burden on medical research. Issue: Oppose inappropriate use of march-in authority. Issue: Educate Congress and the administration about opportunities to strengthen medical research supported by National Institutes of Health (NIH). Issue: Provide input on proposed National Institutes of Health (NIH) optimization frameworks. H.R.1864/S.854 - Risky Research Review Act Issue: Support prevention of unintended consequences from new restrictions on life sciences research. H.R.1863/S.855 - Royalty Transparency Act Issue: Support technical correction to ensure bill does not hamper the National Institutes of Health (NIH) peer review system.
Client expense: $831,429 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institute of Standards & Technology (NIST), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
2025 · second_quarter · Science/Technology
Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235).
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Science/Technology
(H.R.TBD/S.TBD) - FY 2025/FY2026 Commerce, Justice, Science, and Related Agencies Appropriations Act, Title I and Title III, all provisions related to research and education in NASA, NSF, NIST, and NOAA. (H.R.TBD/S.TBD) - FY 2025/2026 Appropriations for Energy and Water Development, Title III - all provisions related to science and research, including nuclear physics research facilities. Full funding for the CHIPS and Science Act of 2022 (P.L. 117-167) - which re-authorized and re-designated the research missions of the National Science Foundation (NSF); spur domestic innovation of advanced technologies through basic and applied research; authorized new R&D programs across federal research agencies; and for other purposes. Proposals to protect university IP, including under potential Bayh-Dole "march in" rights, and mitigate nefarious influence from hostile foreign actors. S.854 - Risky Research Review Act - whole bill, potential impact on bio-medical research, regulatory burden, and efforts to increase oversight and accountability. Proposed regulatory changes to Facilities and Administration (F&A) cost agreements/negotiated indirect cost reimbursements for federally sponsored research. FY2025 Full-Year Continuing Appropriations and Extensions Act (through 9/30/2025) - (P.L. 119-4) EOs, grant rescissions/cancellations, regulatory changes, and policy shifts that affect faculty, researchers, students, programs, and core research and education missions.
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Science/Technology
H.R. 1864 and S. 854: Risky Research Review Act A bill to amend title 31, United States Code, to establish the Life Sciences Research Security Board, and for other purposes (ALL). Presidential and executive actions to cap Facilities and Administrative (F&A) costs for research. Presidential and executive actions to freeze or terminate federal research grants. Presidential and executive actions to pause scientific research agency communications and meetings.
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Health Issues
340B Drug Discount Program ---Executive Order on Access to Affordable Life-Saving Medications ---Program & Oversight Accelerated Approval Artificial Intelligence (AI) Alternative Funding Programs Biodefense Research, Development and Procurement Issues (Non-Funding) ---S.854 Risky Research Review Act ---Bio COMPETES (Draft) ---Biosecurity Infrastructure for Operational (BIO) Early Warning Act (Discussion Draft) ---House GOP RFI on Supply Chain ---American Pandemic Preparedness Plan (AP3) ---MCM PRV Program Reauthorization ---NDAA ---Reasonable Pricing Clauses in BARDA Contracts ---Reauthorization of Pandemic and All-Hazards Preparedness and Advancing (PAHPA) ---Tropical Disease Priority Review Voucher (PRV) Program ---CICP ---White House National Biodefense Strategy ---WHO Pandemic Preparedness Accord Biosimilars ---Bio COMPETES (Draft) ---Biosimilar Copay ---House GOP RFI on Supply Chain ---Interchangeability and Pharmacy Substitution ---Reimbursement Cell & Gene Therapy ---H.R.1672: MINI Act Climate Change ---FY 2025 Appropriations ---FY 2026 Appropriations Data Privacy ---Bio COMPETES (Draft) ---Executive Order on Preventing Access to Americans Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern ---House GOP RFI on Data Privacy ---Clinical Trial Data in China Diagnostics and Personalized Medicine Regulation and Oversight Diversity & Inclusion ---Decentralized Clinical Trials ---Clinical Trial Diversity Drug Evaluation and Review ---Promising Pathway Act ---COVID-19 Lessons Learned ---FDA Hiring Flexibility Drug Importation Drug Manufacturing, Quality & Distribution ---Advanced Manufacturing ---Drug Shortages ---Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy ---Supply Chain Integrity and Traceability ---Compounded Medicines ---House GOP RFI on Supply Chain Drug Patenting ---Interagency Patent Coordination and Improvement Act of 2025 ---Prescription Pricing for the People Act of 2025 ---Preserve Access to Affordable Generics and Biosimilars Act ---Stop STALLING Act ---Patent Thickets ---Restrictions on Intellectual Property Rights Drug Pricing ---FY 2025 Appropriations ---FY 2026 Appropriations ---ORPHAN Cures Act ---Maintaining Investments and New Innovation (MINI) Act ---Ensuring Pathways to Innovative Cures (EPIC) Act ---Interagency Patent Coordination and Improvement Act of 2025 ---Prescription Pricing for the People Act of 2025 ---Pharmacy Benefit Manager Transparency Act of 2025 ---Preserve Access to Affordable Generics and Biosimilars Act ---Stop STALLING Act ---CMMI Authority ---COVID-19 Pricing Related Provisions ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---National Coverage Determination ---PBM Reform ---Patient Cost-Sharing and Implementation ---Strengthening Innovation in Medicare and Medicaid Act Efforts to expand the Bio Economy & Bio Manufacturing Foreign Drug Data Protection Laws ---Bio COMPETES (Draft) ---Executive Order on Preventing Access to Americans Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern ---House GOP RFI on Supply Chain Funding for Antimicrobial Resistance (AMR) Programs ---FY 2025 Appropriations ---FY 2026 Appropriations Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---FY 2025 Appropriations ---FY 2026 Appropriations ---Funding for Strategic National Stockpile ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---MCM PRV ---Reauthorization of Pandemic and All-Hazards Preparedness and Advancing (PAHPA) Funding for the Centers for Disease Control and Prevention Vaccine Programs ---FY 2025 Appropriations ---FY 2026 Appropriations ---VICP ---CICP Funding for FDA ---FY 2025 Appropriations ---FY 2026 Appropriations ---User Fees Funding for Health Resources and Services Administration (HRSA) ---FY 2025 Appropriations ---FY 2026 Appropriations Funding for the HHS Office of Infectious Disease and HIV/AIDS Policy ---FY 2025 Appropriations ---FY 2026 Appropriations Funding for National Institutes of Health ---FY 2025 Appropriations ---FY 2026 Appropriations ---Advanced Research Projects Agency for Health (ARPA-H) ---Funding for Womens Health Research International Reference Pricing Medicaid ---Pharmacy Benefit Manager Transparency Act of 2025 ---Alternative Payment Arrangements for Gene Therapies ---Average Manufacturer Price Calculations ---Coverage of Accelerated Approval Products ---Drug Benefit Design ---Encouraging Innovation Benefit Design to Lower Costs for Seniors Act ---Medicaid Drug Rebate Program Rule ---Pricing and Rebates ---Value-Based Purchasing (VBP) Rule National Defense ---National Defense Authorization Act of 2025 Opioid Crisis ---SUPPORT Act ---Non-Opioid Analgesics ---Transparency ---Coverage and Reimbursement Orphan Drug Issues ---H.R.1262: Give Kids a Chance Act ---H.R.946: ORPHAN Cures Act ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---Pediatric Priority Review Voucher Program ---Orphan Drug Tax Credit Pandemic Preparedness ---Drug Supply Chain Management ---Monoclonal Antibody Coverage and Utilization ---R&D Funding for Medical Countermeasures ---Restrictions on Intellectual Property Rights ---Supply Chain Issues ---Temporarily Refundable R&D Credit ---TRIPS Waiver ---WHO Pandemic Preparedness Accord ---Medical Countermeasures PRV Reauthorization Pharmaceutical and Ag Biotech Tariffs Precision Medicine Initiative Reimbursement and Coverage of Innovative Products ---S.864: HELP Copays Act ---Administration Rebate Rule ---CMMI Authority ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---In-Home Administration of Part B Drugs ---Lower Costs, More Cures Act ---Medicare Part B Physician-Administered Products ---National Coverage Determination ---Patient Cost-Sharing and Smoothing ---Protected Classes ---Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications Vaccines and Infectious Diseases ---FY 2025 Appropriations ---FY 2026 Appropriations ---Adult Immunization ---Countermeasures Injury Compensation Program ---Maternal Immunization ---MCM Manufacturing & Capacity ---MCM PRV Reauthorization ---Monoclonal Antibody Coverage and Utilization ---National Coverage Determination ---Vaccine and Antimicrobial Resistance Product Development and Incentives ---Vaccine Injury Compensation Program ---Vaccine Safety and Quality ---Vaccine Safety net and Vaccine Infrastructure ---Value of Vaccines and Vaccine Confidence ---VICP Loopholes
Client expense: $890,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Science/Technology
H.R. 1048 DETERRENT; S.854 Risky Research Review Act; Open Access to Research; Mental Health
Client expense: $170,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Science/Technology
NIH's proposed cap of 15% on F&A expenditures Updates on impacts of Executive Orders and agency directives on U-M operations and funded research projects CREATE AI Act of 2025 (H.R. 2385) Deterrent Act (H.R. 1048) Risky Research Review Act (S. 854/H.R. 1864) Investing in National Next-Generation Opportunities for Venture Acceleration and Technological Excellence (INNOVATE) Act (S. 853) SBIR/STTR reauthorization - potential provisions related to undue foreign influence Policy related to AI research and funding Issues pertaining to science and security National Defense Authorization Act for FY26 (NDAA)
Client expense: $250,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), SENATE
2025 · first_quarter · Health Issues
Issues related to funding for university research opportunities via Fiscal Year 2025 and Fiscal Year 2026 Federal appropriations; Fiscal Year 2026 defense authorization bill; Issues related to Regional Biocontainment Laboratories (RBLs), cybersecurity, and military health; H.R. 1864 / S. 854 - Risky Research Review Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE